Don’t use aspirin for primary prevention of cardiovascular disease

@article{Barnett2010DontUA,
  title={Don’t use aspirin for primary prevention of cardiovascular disease},
  author={H. Barnett and P. Burrill and I. Iheanacho},
  journal={BMJ : British Medical Journal},
  year={2010},
  volume={340}
}
  • H. Barnett, P. Burrill, I. Iheanacho
  • Published 2010
  • Medicine
  • BMJ : British Medical Journal
    • All patients currently taking aspirin for primary prevention should be reviewed individually to reconsider whether such treatment is justified 
    View on BMJ
    ncbi.nlm.nih.gov
    31 Citations
    Highly Influencial Citations
    1
    Background Citations
    8
    Methods Citations
    1
    31 Citations
    Citation Type

    Citation Type

    Aspirin for Primary Prevention: A Challenging Decision
    • M. Pignone
    • Medicine
    • Journal of the American Heart Association
    • 2014
    • 6
    • PDF
    Antiplatelet combinations for prevention of atherothrombotic events
    • 9
    • Highly Influenced
    • PDF
    Aspirin bleeding in perspective.
    • 3
    Aspirin for primary prevention of cardiovascular disease
    • 34
    Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
    • 44
    PS2-12: Opportunities to Improve Aspirin Utilization for the Primary Prevention of Cardiovascular Disease in a Regional Healthcare System
    • 3
    • PDF
    Aspirin overutilization for the primary prevention of cardiovascular disease
    • 10
    • PDF
    Aspirin for primary prevention of CVD: are the right people using it?
    • 25
    • PDF
    The aspirin controversy in primary prevention
    • 27
    Acetylsalicylic acid use in primary prevention in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) study

    References

    SHOWING 1-10 OF 13 REFERENCES
    BHS reaffirms its guidance
    • P. Sever
    • Medicine
    • BMJ : British Medical Journal
    • 2010
    • 3
    Aspirin for primary prevention of cardiovascular disease?
    • 5
    Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
    • 1,618
    Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
    • 270
    • PDF
    Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
    • 380
    • PDF
    Antiplatelet agents and anticoagulants for hypertension.
    • 23
    European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
    • 6,560
    • PDF
    Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
    • 637
    • PDF
    Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • 5,662
    • PDF
    Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature
    • 333
    • PDF